跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,709 条关于
“FMR1-217”
全部
2,709
临床试验
1,498
药物
850
机构
10
资讯
351
去年
QurAlis Secures Exclusive License for Novel RNA-Targeted Therapy in Fragile X Syndrome
7个月前
Fujirebio Launches Automated pTau 217 CSF Assay for Alzheimer's Disease Research
2年前
Fujirebio Launches Automated pTau 217 Plasma Assay for Alzheimer's Disease Research
2年前
FDA Grants Breakthrough Device Designation for Phospho-Tau 217 Blood Test for Alzheimer's Disease
去年
Spear Bio and Beckman Coulter Receive FDA Breakthrough Device Designations for Alzheimer's Blood Tests
2个月前
Spear Bio to Unveil First Commercially Available Singleplex eMTBR-Tau Immunoassay and Novel pTau 217 Assay at AAIC 2026
11个月前
Harmony Biosciences' ZYN002 Phase 3 Trial Fails to Meet Primary Endpoint in Fragile X Syndrome
17天前
Fujirebio Secures Health Canada Licenses for Blood-Based Neurology Assays
上个月
Marvel Biosciences' MB-204 Reverses Behavioural and Cognitive Deficits in Fragile X Mouse Model, Marking Third Preclinical ASD Success
9个月前
Mirum Pharmaceuticals Initiates Phase II Trial of MRM-3379 for Fragile X Syndrome
第 1 页,共 36 页
上一页
下一页